Clinical Trials Browser

Active not recruiting × Colorectal Neoplasms × Folfox protocol × Clear all

NCT06106308 2026-01-12

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06838338 2026-01-08

JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC

Phase 1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04595266 2025-09-29

LIVERPEARL

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT03635021 2024-10-21

CR-SEQUENCE

Phase 3 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06509880 2024-07-19

ISMCC

Phase 1/2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms